|
2001/2002 Research Operating Funds |
INVESTIGATORS | AGENCY | YEAR | AMOUNT | |
ELEANOR ELSTEIN | Medical Research Council of Canada (Co-applicant) | 2000-2001 | $ 71,247 | /yr |
WILLIAM FOULKES | National Cancer Institute of Canada | 1999-2002 | $ 302,000 | |
US Army | 1999-2002 | US $ 287,000 | ||
US Army - An immunohistochemical study | one year, FY00 award | US $ 50,000 | ||
National Cancer Institute of Canada/CBCRI | one year, FY01 award | $ 45,000 | ||
Cancer Research Society | 2 years, FY01-03 | $ 60,000 | /yr | |
Susan G Komen Breast Cancer Foundation | 2002-2004 | US $ 177,000 | /yr | |
Co-investigator | ||||
National Cancer Institute of Canada/CBCRI (Co-investigator) | PI: Steven Narod, MD 1999-2000 | $ 245,000 | ||
Personal amount | $ 10,000 | /yr | ||
VALÉRIE DÉSILETS | Fonds de Recherche en Sante du Quebec (Co-investigator) | (PI Bruno Piedboeuf) | $ 15,000 | |
Fonds de Recherche en Sante du Quebec (Co- investigator) | (PI
Jaques Michaud |
$ 45,000 | ||
THOMAS HUDSON | Genome Canada/Genome Quebec | 10/2001- 03/2005 | $ 11,134,715 ($ 2,474,381) |
/yr |
Dr. Hudson's allocation - $ 2,226,943 | $ 494,876 | /yr | ||
Genome Canada/Genome Quebec - Expertise Centre: The Montreal Genomics Node of Excellence |
10/2001- 03/2005 | $ 15,192,045 ($ 3,376,010) |
/yr |
|
Dr. Hudson's allocation - $ 3,038,409 | $ 675,202 | /yr | ||
Genome Canada/Genome Quebec - Large-scale project: Atlas of Genomics Profiles of Steroid Action |
11/2001- 03/2005 | $ 20,094,000 ($ 4,465,333) |
/yr |
|
Dr. Hudson's allocation - $ 6,430,080 | $ 1,428,906 | /yr | ||
Canada Foundation for Innovation &
matching funds from Government of Quebec, Biochem Pharma, PE Applied Biosystems & Fisher Scientific - Regional/national facility program |
04/1999 - 06/2003 | $ 8,250,000 ($ 2,062,500) |
/yr |
|
Dr. Hudson's allocation - $ 4,950,000 | $ 1,237,500 | /yr | ||
Bristol-Myers Squibb, Millennium
Pharmaceuticals Inc., Affymetrix Whitehead Institute subcontract - Industrial Award |
10/01-09/02 | US $ 400,000 | ||
Canadian Institutes of Health Research (Operating grant) | 10/2001 - 09/2006 | $ 956,590 ($ 191,318) |
/yr |
|
Dr. Hudson's allocation - $ 459,163 | $ 91,832 | /yr | ||
Juvenile Diabetes Foundation International (Co-investigator) | 11/2001 - 10/2006 | US $ 2,291,169
(US $ 458,233,80) |
/yr |
|
Dr. Hudson's allocation - US $ 340,000 | US $ 68,000 | /yr | ||
Canadian Institute of Health Research (Operating grant) | 04/2001 - 03/2006 | $ 434,595 ($ 86,919) |
/yr |
|
No Funds to T. Hudson | ||||
Medical Research Council of Canada (Operating Grant) | 10/1999 - 09/2002 | $ 488,400 ($ 162,800) |
/yr |
|
Dr. Hudson's allocation - $ 129,000 | $ 43,000 | /yr | ||
Networks of Centres of Excellence -
Phase III Canadian Genetic Diseases Network [CGDN]: |
Michael Hayden and the
members of the CGDN (T.J. Hudson, PI) 04/1998 - 03/2005 |
|||
1) Core Facility - Genotyping: | Amount to T. Hudson: 04/98-03/00 04/00-03/01 04/01-03/02 04/02-03/05 |
TBC: $ 734,991
($ 105,000) $ 95,563 $ 156,613 $ 96,613 $ 96,613 expected |
/yr /yr /yr |
|
2) Expression studies using high-density arrays: | Amount to T. Hudson: 04/98-03/00 04/00-03/02 expected 04/02-03/05 |
TBC: $ 762,132 ($ 108,876) $ 98,566 $ 113,000 $ 113,000 |
/yr /yr /yr /yr |
|
Fonds de Recherche en Sante du Quebec T.J. Hudson: volet bio-puce. Phase I: |
01/2000 - 06/2001 01/00-09/00 10/00-06/01 |
$ 94,797 $ 50,000 |
||
Phase II: Dr. Hudson's allocation |
07/2001 - 06/2002 |
$ 50,000 |
||
Multiple Sclerosis Foundation (Program
Grant) (for equipment, year 1) Dr. Hudson allocation - $207,000 |
04/2000 - 03/2003 plus |
$ 1,413,420 ($ 471,140) $ 85,000 $ 69,000 |
/yr /yr |
|
Montreal Breast Cancer Foundation
(co-investigator) Dr. Hudson allocation - (share to be determined) |
03/2000 - 02/2003 03/00-05/00 06/00-05/01 06/01-05/02 expected 06/02-02/03 |
$ 1,475,098 ($ 491,700) $ 35,000 $ 35,000 $ 35,000 $ 35,000 |
/yr /yr /yr /yr /yr |
|
US Army (Prostate Cancer Opportunities)
(co-investigator) Dr. Hudson allocation - |
09/00 - 08/08 09/99 - 08/00 09/00 - 08/01 09/01 - 08/02 |
US $ 278,288 US $ 21,000 US $ 2,000 US $ 2,000 US $ 17,000 |
||
Social Sciences and Humanities Research
Council of Canada No funds to Hudson |
01/2001 - 12/2005 |
$ 3,210,297 ($ 642,060) |
/yr |
|
KENNETH MORGAN | Networks of Centres of Excellence K. Morgan is one of the investigators in the network (M.R. Hayden, Scientific Director) |
2001-2002 |
$ 165,100 | |
Networks of Centres of Excellence MGHRI as partner Investigators: K. Morgan is one of the investigators in the network (A. Gupta, Program Leader) |
2000-2001 |
$ 25,800 $ 19,733 |
||
Medical Research Council of Canada
(co-applicants) |
April - September 2001 |
$ 66,372 |
||
Canada Foundation for Innovation K. Morgan is one of the team members (T.J. Hudson, Program Leader) |
04/1999-06/2003 |
|
||
Genome Canada/Genome Quebec (T.J.
Hudson, scientific coordinator) |
10/1/2001-03/31/2005 |
|
||
Genome Canada/Genome Quebec (T.J.
Hudson, scientific coordinator) |
10/1/2001-03/31/2005 |
|||
DAVID S. ROSENBLATT | March of Dimes |
06/01 - 05/04 |
US $ 69,707 | /yr |
Canadian Institute for Health Research
- Genetics Group |
10/01 - 09/05 |
$ 103,992 | /yr | |
Garrod Association |
11/01 - 10/02 |
$ 25,000 | /yr | |
GUY ROULEAU | Fonds de Recherche en Sante du Quebec
DNA and lymphoblastoid cell bank for Quebec |
1998-2001 |
$ 14,000 |
/yr |
National Institutes of Health -
Etiology of restless leg syndrome, a sleep disorder |
1999-2002 |
US $ 54,283 |
/yr | |
Canadian Institutes of Health Research |
2000-2003 |
$ 165,000 |
/yr | |
PATRICIA TONIN | Canadian Institute of Health Research |
04/1999 - 03/2002 |
$ 81,000 | /yr |
Canadian Institute of Health Research
(co-investigator) |
10/1999 - 09/2002 |
$ 162,000 | /yr | |
The Cancer Research Society, Inc. |
09/2000 - 08/2002 |
$ 50,000 |
/yr | |
Fonds de la Recherche en Santé du
Québec (investigator) Reseau cancerologie |
01/2000 - 07/2004 |
$ 648,000 | ||
Canadian Foundation for Innovation
(investigator) Host Institution - Université de Montéal |
07/2000 - present |
$ 999,463
(funds not released) |
||
Valorisation-Recherche Québec
(VRQ)(Investigator) |
07/2002 - 06/2006 |
$ 408,000 | /yr | |
Canadian Foundation for Innovation
(CFI) (Investigator) |
07/2002 - 06/2006 |
$ 12,800,000 | ||
Canadian Institutes of Health Research
(CIHR) (Investigator) |
04/2002 - 03/2005 |
$ 111,627 | /yr | |
Genome Canada & Génome Québec
(Investigator) |
07/2002 - 06/2005 |
$ 8,150,000 |
Members | Report | Meetings
Publications | Funds
| Financials
© 2002 Finestone Laboratory